Latest News
Turn Therapeutics Inc.
- WBB Securities upgrades Turn Therapeutics stock rating to hold By Investing.com
- U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside Chat
- Former CDC Director Robert Redfield and Former FDA Commissioner Stephen Hahn Join Turn Therapeutics
- Form DEF 14A Turn Therapeutics Inc. For: 19 October By Investing.com
- Despite Turn Therapeutics' Pullback, Insiders Still Gained US$424k
- Turn Therapeutics Inc. Advanced Charts | TTRX
- Turn Therapeutics (NASDAQ:TTRX) Raised to Hold at Wall Street Zen
- ETFs Investing in Turn Therapeutics Inc. Stocks
- An eczema trial is enrolling about 135 people as Turn Therapeutics (TTRX) awaits results.
- Turn Therapeutics (NASDAQ:TTRX) Cut to Sell at Wall Street Zen
- Turn Therapeutics (NASDAQ:TTRX) Stock Rating Upgraded by Lucid Cap Mkts
- Lucid Capital Markets initiates Turn Therapeutics stock with buy rating
Headlines from the last 30 days, linking to the original publishers. See all market news →